JPRN-UMIN000009648已完成未知
Phase IIa study of SNJ-1656; An exploration study in patients with primary open angle glaucoma or ocular hypertension - An exploration study of SNJ-1656 in patients with primary open angle glaucoma or ocular hypertension
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Any active ocular disease other than glaucoma or OH 2)Active retinal disease 3)Ocular surgery within 3 months 4)History of keratorefractive surgery or filtering surgery 5)History of trabeculotomy in the study eye 6)Anticipated wearing of contact lenses 7)Uncontrolled systemic disease (eg, hepatic, renal, cardiovascular or endocrine system disease) 8)Women who were pregnant, nursing or who were of childbearing potential, or planning a pregnancy 9)Highly visual field loss (eg, the mean deviation <=15dB) 10)Corneal abnormalities that would preclude accurate readings with an applanation tonometer
研究者
相似试验
已完成
不适用
Phase II study of SNJ-2022; An exploration study in patients with primary open angle glaucoma or ocular hypertensioPrimary open-angle glaucoma (POAG) or Ocular hypertension (OH)JPRN-UMIN000019142Senju Pharmaceutical co.,ltd.120
已完成
不适用
Phase IIb study of SNJ-1656; A dose-response study in patients with primary open angle glaucoma or ocular hypertensioJPRN-UMIN000018866Senju Pharmaceutical co.,ltd.180
进行中（未招募）
1 期
An exploratory Phase II Study to demonstrate the Safety and Efficacy of A4250 in Patients with Cholestatic PruritusEUCTR2015-001157-32-DKAlbireo AB24
进行中（未招募）
1 期
A study to demonstrate the Safety and Efficacy of A4250 in Children with Cholestatic Pruritus.EUCTR2015-001157-32-DEAlbireo AB24
进行中（未招募）
1 期
An exploratory Phase II Study to demonstrate the Safety and Efficacy of A4250 in Children with Cholestatic PruritusEUCTR2015-001157-32-SEAlbireo AB24